303 related articles for article (PubMed ID: 15135140)
1. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis.
Rousseau JC; Zhu Y; Miossec P; Vignon E; Sandell LJ; Garnero P; Delmas PD
Osteoarthritis Cartilage; 2004 Jun; 12(6):440-7. PubMed ID: 15135140
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
3. Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide.
Rousseau JC; Sandell LJ; Delmas PD; Garnero P
Methods Mol Med; 2004; 101():25-37. PubMed ID: 15299208
[TBL] [Abstract][Full Text] [Related]
4. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P
Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119
[TBL] [Abstract][Full Text] [Related]
5. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
6. Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis.
Christensen AF; Lottenburger T; Lindegaard H; Christgau S; Hørslev-Petersen K; Junker P
Clin Exp Rheumatol; 2009; 27(2):307-14. PubMed ID: 19473573
[TBL] [Abstract][Full Text] [Related]
7. A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation.
Luo Y; He Y; Reker D; Gudmann NS; Henriksen K; Simonsen O; Ladel C; Michaelis M; Mobasheri A; Karsdal M; Bay-Jensen AC
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404167
[TBL] [Abstract][Full Text] [Related]
8. New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis.
Deberg M; Labasse A; Christgau S; Cloos P; Bang Henriksen D; Chapelle JP; Zegels B; Reginster JY; Henrotin Y
Osteoarthritis Cartilage; 2005 Mar; 13(3):258-65. PubMed ID: 15727893
[TBL] [Abstract][Full Text] [Related]
9. Heritability assessment of cartilage metabolism. A twin study on circulating procollagen IIA N-terminal propeptide (PIIANP).
Munk HL; Svendsen AJ; Hjelmborg Jv; Sorensen GL; Kyvik KO; Junker P
Osteoarthritis Cartilage; 2014 Aug; 22(8):1142-7. PubMed ID: 25008205
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.
Christensen AF; Hørslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P
J Rheumatol; 2010 Jun; 37(6):1113-20. PubMed ID: 20436079
[TBL] [Abstract][Full Text] [Related]
11. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27.
Munk HL; Gudmann NS; Christensen AF; Ejstrup L; Sorensen GL; Loft AG; Bay-Jensen AC; Siebuhr AS; Junker P
Rheumatol Int; 2016 Apr; 36(4):541-9. PubMed ID: 26620690
[TBL] [Abstract][Full Text] [Related]
12. Nitrated type III collagen as a biological marker of nitric oxide-mediated synovial tissue metabolism in osteoarthritis.
Richardot P; Charni-Ben Tabassi N; Toh L; Marotte H; Bay-Jensen AC; Miossec P; Garnero P
Osteoarthritis Cartilage; 2009 Oct; 17(10):1362-7. PubMed ID: 19467351
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study.
Henrotin Y; Bannuru R; Malaise M; Ea HK; Confavreux C; Bentin J; Urbin-Choffray D; Conrozier T; Brasseur JP; Thomas P; Hick AC; Marinello A; Giordan N; Richette P
BMC Musculoskelet Disord; 2019 Jun; 20(1):293. PubMed ID: 31215422
[TBL] [Abstract][Full Text] [Related]
14. Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis.
Berry PA; Jones SW; Cicuttini FM; Wluka AE; Maciewicz RA
Arthritis Rheum; 2011 Mar; 63(3):700-7. PubMed ID: 21305502
[TBL] [Abstract][Full Text] [Related]
15. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
16. Circadian pattern and the effect of standardized physical exercise on procollagen IIA N-peptide (PIIANP) in rheumatoid arthritis at different stages and in healthy individuals.
Christensen AF; Lottenburger T; Lindegaard HM; Junker K; Hørslev-Petersen K; Junker P
Biomarkers; 2010 Feb; 15(1):80-5. PubMed ID: 19814628
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
Wisłowska M; Jakubicz D; Stepień K; Cicha M
Rheumatol Int; 2009 Oct; 29(12):1403-9. PubMed ID: 19219607
[TBL] [Abstract][Full Text] [Related]
18. [Clinical usefulness of the measurement of type-II procollagen carboxypeptide (C-II propeptide, pColl-II-C) in synovial fluid as a marker of collagen metabolism in cartilage].
Shinmei M; Nagaya I; Miyanaga Y; Iwata H; Yamamoto S; Torisu T; Fujii K; Fukubayashi T; Kondo M; Kurosaka M
Ryumachi; 1992 Oct; 32(5):453-60. PubMed ID: 1440081
[TBL] [Abstract][Full Text] [Related]
19. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
20. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
